Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review

• Published in: International journal of molecular sciences 2023-07, Vol.24 (13), p.11130
• Main Authors: Timechko, Elena E, Yakimov, Alexey M, Paramonova, Anastasia I, Usoltseva, Anna A, Utyashev, Nikita P, Ivin, Nikita O, Utyasheva, Anna A, Yakunina, Albina V, Kalinin, Vladimir A, Dmitrenko, Diana V
• Format: Article
• Language: English
• Subjects: Actin; Adult; Age; Amyloid; Annotations; Apolipoprotein E; Apoptosis; Biological activity; Biological markers; Biomarkers; Biomarkers - metabolism; Brain research; Convulsions & seizures; Depolymerization; Epilepsy; Epilepsy - metabolism; Epilepsy, Temporal Lobe - metabolism; Humans; Ions; Laboratories; Mass Spectrometry; Mass spectroscopy; Medical research; Medicine, Experimental; Methods; Molecular modelling; Molecular weight; Oxidative stress; Patients; Peptides; Protein expression; Proteins; Proteins - metabolism; proteomic; Proteomics; Review; Scientific imaging; Searching; Signal transduction; Systematic review; Temporal lobe; Temporal Lobe - metabolism; Temporal lobe epilepsy; Vesicle fusion
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241311130

Temporal lobe epilepsy (TLE) is the most common form of epilepsy in adults. Tissue reorganization at the site of the epileptogenic focus is accompanied by changes in the expression patterns of protein molecules. The study of mRNA and its corresponding proteins is crucial for understanding the pathogenesis of the disease. Protein expression profiles do not always directly correlate with the levels of their transcripts; therefore, it is protein profiling that is no less important for understanding the molecular mechanisms and biological processes of TLE. The study and annotation of proteins that are statistically significantly different in patients with TLE is an approach to search for biomarkers of this disease, various stages of its development, as well as a method for searching for specific targets for the development of a further therapeutic strategy. When writing a systematic review, the following aggregators of scientific journals were used: MDPI, PubMed, ScienceDirect, Springer, and Web of Science. Scientific articles were searched using the following keywords: "proteomic", "mass-spectrometry", "protein expression", "temporal lobe epilepsy", and "biomarkers". Publications from 2003 to the present have been analyzed. Studies of brain tissues, experimental models of epilepsy, as well as biological fluids, were analyzed. For each of the groups, aberrantly expressed proteins found in various studies were isolated. Most of the studies omitted important characteristics of the studied patients, such as: duration of illness, type and response to therapy, gender, etc. Proteins that overlap across different tissue types and different studies have been highlighted: DPYSL, SYT1, STMN1, APOE, NME1, and others. The most common biological processes for them were the positive regulation of neurofibrillary tangle assembly, the regulation of amyloid fibril formation, lipoprotein catabolic process, the positive regulation of vesicle fusion, the positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway, removal of superoxide radicals, axon extension, and the regulation of actin filament depolymerization. MS-based proteomic profiling for a relevant study must accept a number of limitations, the most important of which is the need to compare different types of neurological and, in particular, epileptic disorders. Such a criterion could increase the specificity of the search work and, in the future, lead to the discovery of biomarkers for a parti